Chester County News and Community Website
WASHINGTON, D.C. — In case you missed it, the U.S. Food and Drug Administration granted accelerated approval last week to Inovio Pharmaceuticals’ Voceryq, the first plasmid DNA-based immunotherapy authorized in …
ICYMI: FDA Clears First DNA Immunotherapy for Rare Airway Disease Read More PLYMOUTH MEETING, PA — INOVIO (Nasdaq: INO) has secured U.S. Food and Drug Administration accelerated approval for VOCERYQ, the first plasmid DNA-based immunotherapy authorized in the United States, giving the …
FDA Approves INOVIO’s First DNA Immunotherapy for Rare Disease Read More
WILMINGTON, DE — AstraZeneca and Amgen reported that their immunotherapy TEZSPIRE significantly reduced esophageal inflammation and swallowing difficulties in a Phase III clinical trial, strengthening the companies’ case for expanding …
AstraZeneca, Amgen Report Phase III Success for TEZSPIRE Read More